CAS 612542-14-0

Hh-Ag1.5

Description:

The chemical substance identified as "Hh-Ag1.5" with the CAS number "612542-14-0" is a silver-based compound, likely involving a specific stoichiometry of silver (Ag) in conjunction with another component represented by "Hh." While detailed characteristics such as its molecular structure, physical properties, and specific applications may not be widely documented, silver compounds are generally known for their antimicrobial properties and potential use in various fields, including medicine, electronics, and catalysis. The designation "Ag1.5" suggests a non-integer ratio of silver, indicating a unique formulation that may influence its reactivity and stability. Compounds with silver often exhibit high thermal and electrical conductivity, and their behavior can be significantly affected by the presence of other elements or compounds. For precise applications, safety data, and handling procedures, consulting specific material safety data sheets (MSDS) or scientific literature is recommended.

Formula: C₂₈H₂₆ClF₂N₃OS

Synonyms:

• SAG 1.5
• SAG1.5
• Benzo[b]thiophene-2-carboxamide, 3-chloro-4,7-difluoro-N-[trans-4-(methylamino)cyclohexyl]-N-[[3-(4-pyridinyl)phenyl]methyl]-
• Hh-Ag1.5
• HhAg1.5,Hh-Ag-1.5,Hh Ag1.5
• SAG-1.5

Hh-Ag1.5

CAS: 612542-14-0

Hh-Ag1.5

Purity: ≥98%

Molecular weight: 526.04g/mol

Ref: 54-BUP03438

Hh-Ag1.5

Controlled Product

CAS: 612542-14-0

Formula: C₂₈H₂₆ClF₂N₃OS

Color and Shape: Neat

Molecular weight: 526.04

Ref: TR-H325620

Hh-Ag1.5

CAS: 612542-14-0

Hh-Ag1.5 is a protein that is expressed in the brain and is thought to be involved in the development of cancer. It has been shown to be involved in dopamine production and may play a role in Parkinson's disease. Hh-Ag1.5 has been found to be overexpressed in cervical cancer cells, which may contribute to their chemoresistance to therapy. This protein also plays a role in the development of dyskinesias, which are abnormal movements that can occur as side effects of levodopa treatment for Parkinson's disease, and carcinogenesis, which is the formation of cancerous cells. Hh-Ag1.5 is activated by kinesin and phosphorylated by casein kinase II (CKII).

Formula: C₂₈H₂₆ClF₂N₃OS

Purity: Min. 95%

Molecular weight: 526 g/mol

Ref: 3D-MZA54214

Hh-Ag1.5

CAS: 612542-14-0

Hh-Ag1.5 is a dual Hedgehog/Smo agonist (EC50/Ki: 0.5-2.3 nM), reprograms hepatic stem cells, and differentiates hiPSCs into neural/skin cells.

Formula: C₂₈H₂₆ClF₂N₃OS

Purity: 99.8%

Color and Shape: Solid

Molecular weight: 526.04

Ref: TM-T24754